'A good day': FDA approves world's first RSV vaccine.

Vidal Valero, Myriam

Vidal Valero, Myriam.

Nature ; 617(7960): 234-235, 2023 May.

Article in English | MEDLINE | ID: covidwho-2326882

Subject(s)

Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; United States Food and Drug Administration; Humans; Respiratory Syncytial Virus Infections/prevention & control; Respiratory Syncytial Virus Vaccines/standards; Respiratory Syncytial Virus, Human; United States Food and Drug Administration/legislation & jurisprudence; United States

Keywords

Public health; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: United States Food and Drug Administration / Respiratory Syncytial Virus Infections / Respiratory Syncytial Virus Vaccines Type of study: Prognostic study Topics: Vaccines Limits: Humans Country/Region as subject: North America Language: English Journal: Nature Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google